Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Sort 1247 results by:

Filter Applied. Clear All
Reset All Filters

Search Results for: abortion pill

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove the in-person dispensing requirement for mifepristone.

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation Strategy (REMS) program provisions found the agency lacked sufficient evidence to justify removal of the in-person dispensing requirement.

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data published by the state doesn’t include the total number of abortions obtained by Kentucky residents out of state or the number of self-managed abortions performed by...

Abortion Reporting: Alabama (2025)

Alabama’s 2025 abortion report was published online by the Alabama Department of Public Health (ADPH) in September 2026, showing that three abortions at brick-and-mortar facilities in the state were reported to the Department. The data published by Alabama does not include the total number of abor...

Abortion Reporting: Virginia (2024)

Virginia’s 2024 abortion facility statistics were provided to the Charlotte Lozier Institute (CLI) upon request in July 2026. Preliminary 2025 facility totals were also provided to CLI but will not be covered in this article.

Abortion Reporting: Connecticut (2025)

Connecticut’s 2025 abortion report was provided to the Charlotte Lozier Institute (CLI) by the Connecticut Department of Public Health (CDPH) upon request in August 2026. For the first time since CLI started requesting this data in 2017, the abortion data provided by the CDPH only represented abor...